Back to companies

SEOUL PHARMA CO.,LTD

018680KRKRX

서울제약

Revenue
₩53.6bn
FY2024
Operating income
₩1.5bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)